INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29101, 23941, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29102, 23943, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29103, 27880, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29104, 28384, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29105, 28386, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29106, 28388, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29107, 28390, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29108, 28391, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29109, 28684, 'Tramadol', 'Gastrointestinal Diseases', 'Tramadol may cause spasm of the sphincter of Oddi.  Opioids may increase serum amylase.  Patients with biliary tract disease (including acute pancreatitis) should be monitored for worsening symptoms.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29110, 481, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29111, 482, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29112, 484, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29113, 2999, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29114, 3000, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29115, 3002, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29116, 3003, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29117, 3004, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29118, 11150, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29119, 11576, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29120, 11578, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29121, 11579, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29122, 11580, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29123, 11581, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29124, 11862, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29125, 11863, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29126, 13885, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29127, 23941, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29128, 23943, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29129, 27880, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29130, 28384, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29131, 28386, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29132, 28388, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29133, 28390, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29134, 28391, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29135, 28684, 'Tramadol', 'Hypoglycemia', 'Cases of tramadol-associated hypoglycemia have been reported, some resulting in hospitalization.  In most cases, patients had predisposing risk factors (e.g., diabetes); caution is recommended in these patients.  If hypoglycemia is suspected, blood glucose levels should be monitored and discontinuation of therapy should be considered as appropriate.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29136, 481, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29137, 482, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29138, 484, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29139, 2999, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29140, 3000, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29141, 3002, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29142, 3003, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29143, 3004, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29144, 11150, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29145, 11576, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29146, 11578, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29147, 11579, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29148, 11580, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29149, 11581, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29150, 11862, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29151, 11863, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29152, 13885, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29153, 23941, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29154, 23943, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29155, 27880, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29156, 28384, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29157, 28386, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29158, 28388, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29159, 28390, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29160, 28391, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29161, 28684, 'Tramadol', 'Hypotension', 'Tramadol may cause severe hypotension (including orthostatic hypotension, syncope) in ambulatory patients.  Risk is increased in patients whose ability to maintain blood pressure has already been compromised by reduced blood volume or coadministration of certain CNS depressant drugs; these patients should be monitored for signs of hypotension after starting or titrating tramadol.  In patients with circulatory shock, tramadol may cause vasodilation that can further reduce cardiac output and blood pressure; tramadol should be avoided in patients with circulatory shock.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29162, 481, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29163, 482, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29164, 484, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29165, 2999, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29166, 3000, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29167, 3002, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29168, 3003, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29169, 3004, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29170, 11150, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29171, 11576, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29172, 11578, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29173, 11579, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29174, 11580, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29175, 11581, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29176, 11862, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29177, 11863, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29178, 13885, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29179, 23941, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29180, 23943, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29181, 27880, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29182, 28384, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29183, 28386, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29184, 28388, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29185, 28390, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29186, 28391, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29187, 28684, 'Tramadol', 'Intracranial Hypertension', 'Opioids may obscure the clinical course in a patient with a head injury.  The use of tramadol should be avoided in patients with impaired consciousness or coma.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29188, 481, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29189, 482, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29190, 484, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29191, 2999, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29192, 3000, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29193, 3002, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29194, 3003, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29195, 3004, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29196, 11150, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29197, 11576, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29198, 11578, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29199, 11579, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
INSERT OR IGNORE INTO disease_interactions (id, med_id, trade_name, disease_name, interaction_text, severity, reference_text, source, created_at) VALUES (29200, 11580, 'Tramadol', 'Liver Diseases', 'Tramadol is converted by the liver to several metabolites, one of which (referred to as M1) is pharmacologically active and a more potent analgesic than tramadol itself.  The metabolism of both tramadol and M1 has been shown to decrease in patients with advanced cirrhosis of the liver, resulting in increased exposure to tramadol as well as substantially prolonged elimination half-lives for both tramadol and M1.  Therapy with tramadol should be administered cautiously in patients with liver dysfunction.  In patients with severe liver dysfunction, dosage reduction is recommended with the immediate-release formulations, while the extended-release formulations should not be used.', '2', '', 'DDInter', 0);
